Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biochem Pharma (BCHE) -- Ignore unavailable to you. Want to Upgrade?

To: JDN who wrote (717)	3/6/2000 2:52:00 PM
From: tuck	Respond to of 783

JDN, I think your patience will be rewarded. Right now they are in transition stage, which adds to uncertainty in an uncertain industry. The Street doesn't like this. Just watch management's execution; if no major stumbles on the road to pharmahood, then this is a ground floor opportunity. 1st fill on sold puts. Will sell more if I'm wrong about this being a bottom. This has at least been a good trading stock for me so far. But my outlook is shorter term, don't let it skew yours. When I exit it means nothing about what I think about the company's value unless I specifically say so. I don't see myself calling BCHE overvalued for a while ;~} Besides, I believe we are in for some clinical news soon. Methinks that's why there are some big blocks bottom fishing today, as if the hiring of a PR man justifies the loss of millions in market cap. Cheers, Tuck